drugset / Trial / NCT00586521

BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)

NCT00586521

Phase 4 Completed 20 enrolled Bayer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the effect of prophylactic treatment on the number of joint bleeds and quality of life in severe hemophilia A subjects compared to on-demand treatment in a one-group two-treatment schedule design. In addition, the effect of prophylactic treatment on the joint function, the number of all bleeds, and on the quality of life compared to on-demand treatment and health-economic data will be assessed.

Timeline

Start
2006-02
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ADVATE Protein / enzyme biologic 20 iu/kg
Subject ADVATE Protein / enzyme biologic 40 iu/kg

Indications